Company profile · Riga, Latvia

AS Grindeks

Pharma Manufacturing · Commercial / Industrial

Industrial API and dosage-form platform with Grade A-D production, synthesis units, and ISO-backed quality-control laboratories.

Lead
Jānis Romanovskis (verified ↗)
Address
Krustpils iela 53, Riga, LV-1057, Latvia (source ↗)
Compliance
GMP Certified · ISO 9001 · ISO 14001 · EU GDP · ISO 45001 · ISO 50001
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Commercial / Industrial
Capabilities
API Synthesis · Final Dosage Forms · Quality Control
Founded
1946
Headcount
1001-5000
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Jānis Romanovskis

Chairman of the Board and CEO

Check official leadership source
Full addressKrustpils iela 53, Riga, LV-1057, Latvia
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Grindeks contacts page naming Krustpils iela 53, Riga as the headquarters and production address.

Open source
Operating profile

Commercial / Industrial

Riga, Latvia. Pharma Manufacturing. Review completed on 14 Mar 2026.

2026 technical specializationPharma Manufacturing
Core capabilities
API SynthesisFinal Dosage FormsQuality Control
Governance

State Agency of Medicines (Latvia)

GMP Certified, ISO 9001, ISO 14001, EU GDP, ISO 45001, ISO 50001

Latest public certification

ISO/IEC 17025 accreditation update: 12 Feb 2025

Grindeks quality control laboratory accreditation update.
Editorial note

Pharma Manufacturing

Industrial API and dosage-form platform with Grade A-D production, synthesis units, and ISO-backed quality-control laboratories.

Related companies
Editorial note

Grindeks remains a Baltic manufacturing anchor with Jānis Romanovskis leading the board while the Riga headquarters continues to operate as the group's main production and quality site.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

API Synthesis
Final Dosage Forms
Quality Control
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceGrindeks official CEO appointment release.Source origin: grindeks.comOpen source
Supporting evidenceGrindeks Board page.Source origin: grindeks.comOpen source
Physical-site evidenceOfficial Grindeks contacts page naming Krustpils iela 53, Riga as the headquarters and production address.Source origin: grindeks.comOpen source
Certification evidenceGrindeks quality control laboratory accreditation update.Source origin: grindeks.comOpen source
Infrastructure

Declared infrastructure

Industrial Synthesis Units
Mass Spectrometers
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
VERIFIED ACTIVE 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is AS Grindeks located?
AS Grindeks operates from Krustpils iela 53, Riga, LV-1057, Latvia, Riga, Latvia.
Who runs AS Grindeks?
AS Grindeks is led by Jānis Romanovskis, Chairman of the Board and CEO. Verified 14 Mar 2026.
What certifications does AS Grindeks hold?
AS Grindeks is documented under GMP Certified, ISO 9001, ISO 14001, EU GDP, ISO 45001, ISO 50001.
What does AS Grindeks do?
Industrial API and dosage-form platform with Grade A-D production, synthesis units, and ISO-backed quality-control laboratories. Core capabilities: API Synthesis, Final Dosage Forms, Quality Control.
Editorial context

Related technical briefs

Briefs that name Riga as a covered market or city.